CD177 and cancer: Noncovalent coupling of cell surface receptor binding molecules can be achieved with bispecific antibodies which recognize the residues of the capsid and a cell-specific receptor on cancer cells [131] or by chemical coupling of biotin to amino groups of capsid surface-exposed arginine (R) or lysine (K) residues which after modification could bind to avidin-linked receptor binding peptides [132].